The Role of the TGF-β Coreceptor Endoglin in Cancer

Endoglin (CD105) is an auxiliary membrane receptor of transforming growth factor beta (TGF-β) that interacts with type I and type II TGF-β receptors and modulates TGF-β signaling. Endoglin is overexpressed in the tumor-associated vascular endothelium, where it modulates angiogenesis. This feature ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Eduardo Pérez-Gómez, Gaelle del Castillo, Juan Francisco Santibáñez, Jose Miguel Lêpez-Novoa, Carmelo Bernabéu, Miguel Quintanilla
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2010.230
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558098482462720
author Eduardo Pérez-Gómez
Gaelle del Castillo
Juan Francisco Santibáñez
Jose Miguel Lêpez-Novoa
Carmelo Bernabéu
Miguel Quintanilla
author_facet Eduardo Pérez-Gómez
Gaelle del Castillo
Juan Francisco Santibáñez
Jose Miguel Lêpez-Novoa
Carmelo Bernabéu
Miguel Quintanilla
author_sort Eduardo Pérez-Gómez
collection DOAJ
description Endoglin (CD105) is an auxiliary membrane receptor of transforming growth factor beta (TGF-β) that interacts with type I and type II TGF-β receptors and modulates TGF-β signaling. Endoglin is overexpressed in the tumor-associated vascular endothelium, where it modulates angiogenesis. This feature makes endoglin a promising target for antiangiogenic cancer therapy. In addition, recent studies on human and experimental models of carcinogenesis point to an important tumor cell–autonomous role of endoglin by regulating proliferation, migration, invasion, and metastasis. These studies suggest that endoglin behaves as a suppressor of malignancy in experimental and human epithelial carcinogenesis, although it can also promote metastasis in other types of cancer. In this review, we evaluate the implication of endoglin in tumor development underlying studies developed in our laboratories in recent years.
format Article
id doaj-art-5957205d01a545718161703fe3924547
institution Kabale University
issn 1537-744X
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-5957205d01a545718161703fe39245472025-02-03T01:33:18ZengWileyThe Scientific World Journal1537-744X2010-01-01102367238410.1100/tsw.2010.230The Role of the TGF-β Coreceptor Endoglin in CancerEduardo Pérez-Gómez0Gaelle del Castillo1Juan Francisco Santibáñez2Jose Miguel Lêpez-Novoa3Carmelo Bernabéu4Miguel Quintanilla5Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autênoma de Madrid, Madrid, SpainInstituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autênoma de Madrid, Madrid, SpainInstitute for Medical Research, University of Belgrado, Belgrado, SerbiaInstituto Reina Sofía de Investigaciên Nefrolêgica, Departamento de Fisiologia y Farmacología, Universidad de Salamanca, Salamanca, SpainCentro de Investigaciones Biológicas, CSIC, and CIBER de Enfermedades Raras (CIBERER), Madrid, SpainInstituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autênoma de Madrid, Madrid, SpainEndoglin (CD105) is an auxiliary membrane receptor of transforming growth factor beta (TGF-β) that interacts with type I and type II TGF-β receptors and modulates TGF-β signaling. Endoglin is overexpressed in the tumor-associated vascular endothelium, where it modulates angiogenesis. This feature makes endoglin a promising target for antiangiogenic cancer therapy. In addition, recent studies on human and experimental models of carcinogenesis point to an important tumor cell–autonomous role of endoglin by regulating proliferation, migration, invasion, and metastasis. These studies suggest that endoglin behaves as a suppressor of malignancy in experimental and human epithelial carcinogenesis, although it can also promote metastasis in other types of cancer. In this review, we evaluate the implication of endoglin in tumor development underlying studies developed in our laboratories in recent years.http://dx.doi.org/10.1100/tsw.2010.230
spellingShingle Eduardo Pérez-Gómez
Gaelle del Castillo
Juan Francisco Santibáñez
Jose Miguel Lêpez-Novoa
Carmelo Bernabéu
Miguel Quintanilla
The Role of the TGF-β Coreceptor Endoglin in Cancer
The Scientific World Journal
title The Role of the TGF-β Coreceptor Endoglin in Cancer
title_full The Role of the TGF-β Coreceptor Endoglin in Cancer
title_fullStr The Role of the TGF-β Coreceptor Endoglin in Cancer
title_full_unstemmed The Role of the TGF-β Coreceptor Endoglin in Cancer
title_short The Role of the TGF-β Coreceptor Endoglin in Cancer
title_sort role of the tgf β coreceptor endoglin in cancer
url http://dx.doi.org/10.1100/tsw.2010.230
work_keys_str_mv AT eduardoperezgomez theroleofthetgfbcoreceptorendoglinincancer
AT gaelledelcastillo theroleofthetgfbcoreceptorendoglinincancer
AT juanfranciscosantibanez theroleofthetgfbcoreceptorendoglinincancer
AT josemiguellepeznovoa theroleofthetgfbcoreceptorendoglinincancer
AT carmelobernabeu theroleofthetgfbcoreceptorendoglinincancer
AT miguelquintanilla theroleofthetgfbcoreceptorendoglinincancer
AT eduardoperezgomez roleofthetgfbcoreceptorendoglinincancer
AT gaelledelcastillo roleofthetgfbcoreceptorendoglinincancer
AT juanfranciscosantibanez roleofthetgfbcoreceptorendoglinincancer
AT josemiguellepeznovoa roleofthetgfbcoreceptorendoglinincancer
AT carmelobernabeu roleofthetgfbcoreceptorendoglinincancer
AT miguelquintanilla roleofthetgfbcoreceptorendoglinincancer